1185767-02-5

Basic information

• Product Name: 5,7-Difluoro-quinoline-6-carbaldehyde
• Synonyms: 5,7-Difluoro-quinoline-6-carbaldehyde
• CAS NO: 1185767-02-5
• Molecular Formula: C10H5F2NO
• Molecular Weight: 193.15
• Mol File: 1185767-02-5.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5,7-Difluoro-quinoline-6-carbaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 5,7-Difluoro-quinoline-6-carbaldehyde(1185767-02-5)
• EPA Substance Registry System: 5,7-Difluoro-quinoline-6-carbaldehyde(1185767-02-5)

Safety Data

• Hazardous Substances Data: 1185767-02-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
5,7-Difluoro-quinoline-6-carbaldehyde is used as a key intermediate in the synthesis of various pharmaceuticals for its potential to contribute to the development of new drugs with enhanced properties. Its incorporation into drug molecules can improve their efficacy and pharmacokinetics.
Used in Agrochemical Industry:
In the agrochemical sector, 5,7-Difluoro-quinoline-6-carbaldehyde is employed as an intermediate in the production of agrochemicals, where it can enhance the effectiveness of pesticides and other agricultural chemicals, potentially increasing crop yields and protecting plants from diseases and pests.
Used in Material Science:
5,7-Difluoro-quinoline-6-carbaldehyde is used as a building block in material science for the development of novel materials. Its unique properties, including fluorescence and the presence of fluorine atoms, can be leveraged to create materials with specific characteristics for various applications, such as in sensors or optoelectronics.
Used in Organic Chemistry Research:
As a compound with interesting structural features and biological activities, 5,7-Difluoro-quinoline-6-carbaldehyde is used in organic chemistry research to explore new synthetic pathways, understand its reactivity, and discover new derivatives with potential applications in different fields.
Used in Antimicrobial Applications:
Due to its antibacterial and antifungal properties, 5,7-Difluoro-quinoline-6-carbaldehyde is used as an antimicrobial agent. It can be incorporated into various products to prevent the growth of harmful microorganisms, contributing to the preservation of materials and the control of infections in medical and other settings.

Upstream product

• 1022091-49-1 6-bromo-5,7-difluoroquinoline 
• 68-12-2 N,N-dimethyl-formamide 
• 372-39-4 3,5-difluoroaniline 
• 203302-95-8 4-bromo-3,5-difluorophenylamine 
• 1185767-03-6 6-vinyl-5,7-difluoroquinoline 

Relevant articles and documents

Quinoline compounds and preparation method thereof, and intermediate, pharmaceutical composition and application of quinoline compounds

The invention discloses quinoline compounds and a preparation method thereof, and an intermediate, a pharmaceutical composition and application of quinoline compounds. The invention provides quinoline compounds disclosed as Formula 1, and pharmaceutically acceptable salts, solvates, metabolites, metabolism precursors or pharmaceutical precursors thereof. The quinoline compounds have favorable inhibitory effects on tyrosine kinase C-Met, and can be used for preparing drugs for prevention, treatment or auxiliary treatment on multiple diseases related to C-Met expression or activity, and especially neoplastic diseases.

HETEROCYCLIC HYDRAZONE COMPOUNDS AND THEIR USES TO TREAT CANCER AND INFLAMMATION

The invention relates to compounds of formula (I) and salts thereof: wherein the substituents are as defined in the specification; a compound of formula (I) for use in the treatment of the human or animal body, in particular with regard to c-Met tyrosine kinase mediated diseases or conditions; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner, and processes for the preparation of a compound of formula (I).

3-HETEROARYLMETHYL-IMIDAZO[1,2-B]PYRIDAZIN-6-YL DERIVATIVES AS C-MET TYROSINE KINASE MODULATORS

The invention relates to compounds of formula (I) and salts thereof, wherein the substituents are as defined in the specification, the application of a compound of formula (I) in a process for the treatment of the human or animal body, in particular with

IMIDAZO [1,2-B] PYRIDAZINE DERIVATIVES FOR THE TREATMENT OF C-MET TYROSINE KINASE MEDIATED DISEASE

The invention relates to compounds of formula (I) and salts thereof, formula (I) wherein the substituents are as defined in the specification, the application of a compound of formula (I) in a process for the treatment of the human or animal body, in particular with regard to C-Met tyrosine kinase mediated disease; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharamaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner; processes for the preparation of a compound of formula (I).